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Abstract
Background: Physical activity (PA) is beneficial in reducing pain and improving function in lower limb
osteoarthritis (OA), and is recommended as a first line treatment. Self-administered questionnaires are used to
assess PA, but knowledge about reliability and validity of these PA questionnaires are limited, in particular for
patients with OA. The purpose of this study was to evaluate the reliability and validity of the Physical Activity Scale
for the Elderly (PASE) in patients with hip OA.
Methods: Forty patients with hip OA (20 men and 20 women, mean age 61.3 ± 10 years) were included. For test-
retest reliability PASE was administered twice with a mean time between tests of 9 ± 4 days. Intraclass correlation
coefficient (ICC), standard error of measurement (SEM) and minimal detectable change (MDC) were calculated for
the total score and for the particular items assessing different PA intensity levels. In addition a Bland-Altman
analysis for the total PASE score was performed. Construct validity was evaluated by comparing the PASE results
with the Actigraph GT1M accelerometer and the International Physical Activity Questionnaire (IPAQ), using the
Spearman rank correlation coefficient.
Results: ICC for the total PASE score was 0.78, with relatively large error of measurement; SEM = 31 and MDC =
87. ICC for the intensity items was 0.20 for moderate PA intensity, 0.46 for light PA intensity and to 0.68 for
vigorous PA intensity. The Spearman rank correlation coefficient between the Actigraph GT1M total counts per
minute and the total PASE score was 0.30 (p = 0.089), and ranging from 0.20-0.38 for the different PA intensity
categories. The Spearman rank correlation between IPAQ and PASE was 0.61 (p = 0.001) for the total scores.
Conclusions: In patients with hip OA the test-retest reliability of the total PASE score was moderate, with
acceptable ICC, but with large measurement errors. The construct validity of the PASE was poor when compared
to the Actigraph GT1M accelerometer. Test-retest reliability and construct validity revealed that the PASE was
unable to assess PA intensity levels. PASE is not recommended as a valid tool to examine PA level for patients with
hip OA.
Background
Physical inactivity is considered to be a risk factor for
many life-threatening diseases and regarded as a major
burden on general public health, therefore international
and national guidelines recommend that all adults
engage in moderate to vigorous physical activity
(MVPA) for at least 30 minutes per day[1-3]. Patients
with OA are found to be less physically active than the
general adult population, and fewer fulfill the recom-
mendations of 30 minutes MVPA per day[4,5]. Being
physically active according to the recommended guide-
lines is beneficial in preserving function and reduce
symptoms[6], and PA is recommended as a first line
treatment that should be offered to all individuals with
hip or knee OA[7,8]. The efficacy and importance of PA
and exercise for patients with OA of the lower limbs
have been emphasized in several studies[9-12].
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essential for studying its health effects. Frequency, dura-
tion and intensity are important factors when evaluating
PA as a protective factor against OA progression and
functional decline[13]. Numerous methods for assessing
PA are available, and can be categorized into three main
groups; self-reported assessments (questionnaires, rating
scales, diaries), activity monitors (accelerometers, ped-
ometers, heart rate monitors) and direct assessment of
energy expenditure (doubly labelled water, indirect
calorimetry). Self-administered questionnaires, including
the Physical Activity Scale for the Elderly (PASE), can
potentially capture all types of activities and allow grad-
ing by intensity. They are widely used, due to being
inexpensive and easy to administer, and are considered
particularly useful in large epidemiological and longitu-
dinal studies. However, questionnaires have obvious
weaknesses considering recall and reporting bias. In
contrast, accelerometers offer a method for measuring
body acceleration, and thereby quantify amount and
intensity of movement[14]. Accelerometers often serve
as a comparator when validity of questionnaires is evalu-
ated, as they are expected to measure the same con-
struct[15].
Despite the fact that many self-administered question-
naires are available, evidence for validity and reliability
is limited [13]. PASE has been found to significantly
correlate in expected directions with physical perfor-
mance, knee pain and knee functioning in patients with
knee pain[6,16], and previous studies have reported cor-
relation coefficients of 0.16, 0.43 and 0.49 when com-
pared to an accelerometer in the general, elderly
population[17-19]. However, the validity of PASE has
not been evaluated in patients with hip OA by compar-
ing it to an accelerometer. The purpose of this study
was therefore to evaluate the construct validity and the
test-retest reliability of the Norwegian version of the
Physical Activity Scale for the Elderly (PASE) in patients
with hip OA.
Methods
Subjects
Forty patients with hip OA from a larger ongoing ran-
domized controlled trial (RCT), evaluating the effect of
patient education and supervised exercise in patients
with hip OA[20], were included. Inclusion criteria were
age between 40 and 80 years, uni- or bilateral hip pain
for more than three months, Harris Hip Score[21]
between 60 and 95, and radiographically verified hip OA
according to Danielsson’s criteria[22]. Patients with low
back pain or knee pain, trauma or functional impair-
ments, or diseases that might interfere with participation
were excluded. Patients who had gone through total hip
replacement surgery (THR) since inclusion in the RCT
were also excluded. During September 2010, 61 patients
who had been included in the original RCT between
2006 and 2008, were re-contacted and requested to par-
ticipate in this validation study. Twelve patients did not
respond, eight had gone through THR surgery and one
lived abroad. The remaining 40 patients agreed to parti-
cipation and were included in the study.
Anthropometrical (age, gender, height, weight) and
sociodemographic data (work status, educational level),
as well as data on Harris Hip Score, minimal joint space
width, bilateral hip pain and pain duration was recorded
at time of inclusion in the original RCT. Data on age
has been altered to reflect the actual age at the time of
data collection in this validation study.
The study was approved by The Regional Committee
for Medical Research Ethics for South-Eastern Norway.
All participants received both oral and written informa-
tion and signed a written informed consent, before
inclusion. The data collection was carried out in accor-
dance with the directives given in the Declaration of
Helsinki.
Outcome measurements
PASE is a brief, self-administered, 7-day recall question-
naire designed to assess PA in older adults[23]. It has
also been used in studies assessing PA in patients with
OA[24,25]. In this study we used the Norwegian version
of the PASE, which was slightly adapted when translated
due to cultural differences[26], i.e. the question in the
original version addressing walking activities was incor-
porated in the three questions addressing light, moder-
ate and vigorous PA activity. It consists of 24 questions
in total and the overall PASE score ranges from 0-315
(and above). The instructions for use and scoring given
in the PASE Administration and Scoring Manual were
followed (http://www.neri.org). The questions included
in PASE address leisure-time, household and work-
related PA, with the different items weighted differently.
Participation in leisure-time PA, including light, moder-
ate and vigorous PA intensity, and strengthening activ-
ities, is recorded as never, seldom (1-2 days per week),
sometimes (3-4 days per week), and often (5-7 days per
week). Duration is categorized as less than 1 hour, 1-2
hours, 2-4 hours and more than 4 hours. Housework
activities are recorded as yes or no, and paid or unpaid
work, requiring some PA, is recorded in hours/week.
The total PASE score is computed by multiplying time
spent in each activity (hours per day) (for leisure and
work-related activities) or participation (yes/no) in an
activity (for household-related activities), by empirically
derived weighting, and then summarizing all items[26].
From the PASE recordings we calculated the total PASE
score, representing the overall activity level. In addition
we calculated the PASE score for household-/work-
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PA, as well as the PASE score from the items addressing
light, moderate and vigorous PA intensity.
Construct validity of the PASE was evaluated by com-
paring it to the Actigraph GT1M accelerometer (Acti-
Graph, LLC, Pensacola, FL, USA) and to the short form
of the International Physical Activity Questionnaire
(IPAQ). The Actigraph GT1M is an electronic motion
sensor comprising a single plane (vertical) accelerometer.
Movement in the vertical plane is detected as a combined
function of the frequency and intensity of the movement.
Counts are summed over 10 second epochs and down-
loaded to memory. All sequences of 60 minutes or more
of consecutive zero counts were excluded from each indi-
viduals recording. For the analyses, a valid day was
defined as having 10 or more hours of monitor wear. Six
or more valid days of registration were considered suffi-
cient. Accelerometers were initialized and downloaded
using the software program ActiLife (ActiGraph, LLC,
Pensacola, FL, US). Data were reduced using the SAS-
based software program (SAS Institute Inc., Cary, North
Carolina, USA) called CSA Analyzer (csa.svenssonsport.
dk). From the Actigraph GT1M registrations we calcu-
lated average counts per minute representing the overall
activity level. In addition we calculated total minutes
spent in 0-99 counts per minute, 100-2019 counts per
minute, 2020-5999 counts per minute and above 6000
counts per minute, representing minutes spent inactive,
and in light, moderate and vigorous PA intensity, respec-
tively[27,28]. The proportion of patients who achieved
the recommended 30 minutes of daily MVPA was estab-
lished by dividing total time in MVPA by the number of
valid days of recording, giving an average (minutes per
day) across the assessment period.
The development of the IPAQ was initiated in 1996,
and conducted by an International Consensus Group,
with the intention to develop a measure suitable for
assessing population levels of PA across countries[29].
IPAQ is a short, self-administered, 7-day recall question-
naire designed for assessing PA in adults. It consists of
seven questions which include PA in all contexts of
everyday life, and addresses days, hours and minutes
spent on vigorous PA, moderate PA and walking. A
question on sitting hours per day is also included. The
IPAQ is scored by using the Metabolic Equivalent of
Task (MET) method, where different activities and levels
of intensity are given different MET estimates. In this
study the Norwegian version of the IPAQ short form
was used, as well as instructions given in the IPAQ
Scoring Protocol, both described at http://www.ipaq.ki.
s e .F o rt h eI P A Qw ec a l c u l a ted the total MET-minutes
per week, representing the overall activity level. In addi-
tion we calculated MET-minutes per week for walking
activities, moderate activities and vigorous activities.
Procedures
Data collection for the evaluation of test-retest reliability
and construct validity was carried out during October
2010. The Actigraph GT1M was administered by postal
mail to all included patients, and it was worn in an elas-
tic belt placed on the right hip. All participants were
instructed to wear the accelerometer during all waking
hours, except during bathing and swimming, over a per-
iod of seven consecutive days (1
th -7
th day), se Figure 1.
The questionnaires, PASE and IPAQ, was administered
to the participants by mail on the 7
th day, and filled in
on the 8
th day, the day after finishing the accelerometry
registration period, and returned by mail. For evaluation
of test-retest reliability PASE was also filled out seven
days later (on the 15
th day).
Analysis
Baseline characteristics and descriptive data for the Acti-
graph GT1M, the PASE and the IPAQ calculations are
presented as mean and standard deviation (SD) or num-
ber and percentage (%). To evaluate the test-retest relia-
bility for the total PASE score the intraclass correlation
coefficient (ICC2.1 - two-way random effect model, abso-
lute agreement) was calculated. In addition, ICC2.1 was
calculated for the sub-score for household/work-related
PA, the sub-score for leisure-time PA, and for the PASE
score of the items for light, moderate and vigorous PA
intensity. Measurement error was assessed by estimating
the standard error of measurement (SEM), minimal
detectable change (MDC) and limits of agreement
(LoA). SEM was calculated as the square root of the
within-subject total variance of an ANOVA analysis,
SEM = √vartot, and the MDC was calculated as MDC =
1.96 × √2×SEM [30]. LoA were calculated according to
the Bland-Altman method and a Bland Altman plot for
visual judgment of the relationship between the indivi-
dual mean total PASE score of the test and retest, and
the difference in total PASE score between test and ret-
est was made[31].
The construct validity of the PASE was evaluated by
calculating the Spearmans rank correlation coefficients
(r)f o rt h et o t a lP A S Es c o r ea n dt h eA c t i g r a p hG T 1 M
(total counts per minute), and for the total PASE score
and the total IPAQ score (total MET-minutes per
week). A priori hypotheses were made based on pre-
vious studies comparing PA questionnaires and PA mea-
sured by accelerometry. As recommended by Terwee et
al.[15], the most similar constructs of the PASE and the
Actigraph GT1M were compared. We hypothesized a
low to moderate positive correlation (r between 0.15
and 0.5) between the total PASE score and the Acti-
graph GT1M counts per min. We hypothesized a mod-
erate to strong positive correlation (r between 0.6 and
0.9) between the total PASE score and the IPAQ total
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the correlation between a PA questionnaire (total score)
and accelerometry (counts per minute) should exceed
0.5. We therefore interpreted this as a cut-off for accep-
table validity.
In addition, Spearmans r were calculated for the
PASE items for light, moderate and vigorous PA inten-
sity and the different intensity levels/categories assessed
by the Actigraph GT1M and IPAQ. For these compari-
sons the approach was more explorative, but the PASE
score for the different intensity items were hypothesized
to correlate most strongly with the respective categories
of the Actigraph GT1M and the IPAQ as follows: 1) the
PASE light PA intensity with the Actigraph GT1M min-
utes of light PA intensity and the IPAQ walking MET-
minutes per week, 2) the PASE moderate PA intensity
with the Actigraph GT1M minutes of moderate PA
intensity and the IPAQ walking MET-minutes per week
and IPAQ moderate MET-minutes per week, and 3) the
PASE vigorous PA intensity with the Actigraph GT1M
minutes of vigorous PA intensity and the IPAQ vigorous
MET-minutes per week.
All statistical analyses were performed using the
PASW Statistics 18 for Windows (IBM Corporation,
Route, Somers, NY, USA).
Results
All 40 patients completed PASE at day 8, but at day 15
PASE were missing or inadequately filled out for seven
patients. Calculation of the test-retest reliability was
therefore based on the 33 patients with complete PASE
questionnaires both at test and retest. Thirty-six patients
had completed the Actigraph GT1M recording period
and had readable files. Two patients returned the Acti-
graph GT1M unused, and data from two patients were
not successfully downloaded. Six or more days of regis-
tration were considered to be sufficient. Three patients
had less than six days of registration and were thus
excluded from the analysis. In total, recordings from 33
patients were included to calculate correlation coeffi-
cients between the PASE and the Actigraph GT1M. The
average days of registration were 7.0 (0.6). For the
IPAQ, 15 patients had missing or incomplete question-
naires, leaving 25 patients to be included to calculate
correlation coefficients between the PASE and the
IPAQ. This was mainly due to inability to calculate the
I P A Qs c o r eb e c a u s et h er e s p o n s ea l t e r n a t i v e“don’t
know” was chosen.
Demographic and clinical characteristics of the
patients are shown in Table 1. Based on the Actigraph
GT1M measurements 67% fulfilled the recommenda-
tions of at least 30 minutes of accumulated MVPA per
day, and 30% fulfilled the recommendations of at least
30 minutes of MVPA per day in blocks of minimum 10
minutes. At average the patients spent 45 (32) minutes
per day on MVPA.
Test-retest reliability
Mean days between test and retest was nine days (SD
4.0), ranging from six to 25 days. Mean PASE score at
test (n = 33) was 143 (SD 71) and at retest 125 (SD 56).
The decline in the total PASE score from test to retest
was significant (p = 0.02), but no significant differences
was revealed for any of the sub scores/items. ICC2.1 for
the total PASE score was 0.77, SEM was 31 and MDC
was 87 (Table 2). Test-retest values for the different sub
Figure 1 Schematic view of the timeline of the study. PASE: Physical Activity Scale for the Elderly; IPAQ: International Physical Activity
Questionnaire.
Table 1 Demographics and clinical characteristics of the
40 patients
Variables
Age in years, mean (SD) 61.3 (10.0)
Men, n (%) 20 (50)
Body mass index, kg/m
2, mean (SD) 24.5 (3.6)
Years of education, n (%)
7-9 years 11 (28.2)
10-12 years 13 (33.3)
> 12 years 15 (38.5)
Work status, n (%)
At work 26 (66.7%)
Retired 10 (25.6%)
Sick-leave 3 (7.8%)
Bilateral hip-pain, n (%) 30 (75)
Minimal joint space in most painful hip, mm, mean (SD) 2.5 (0.9)
Pain duration, months, mean (SD) 49.8 (55.4)
Harris Hip Score, mean (SD) 80.7 (7.9)
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man plot for the total PASE score is shown in Figure 2.
The lower LoA was -65 and the upper LoA was 100.
One out of 33 values (3%) was outside the LoA.
Construct validity
The Spearman’s rank correlation coefficient (r)b e t w e e n
the PASE score and the Actigraph GT1M, and the
PASE score and the IPAQ score is shown in Table 3.
The correlation between the total PASE score and the
Actigraph GT1M mean counts per minute was 0.30(p =
0.089). When comparing the total PASE score with the
IPAQ total MET-minutes per week the correlation coef-
ficient was 0.61 (p = 0.001).
For the different PA intensity items of the PASE we
expected higher correlation coefficients with the respec-
tive categories of the Actigraph and the IPAQ. These
comparisons are highlighted in Table 3. The correlation
coefficients ranged from 0.10 to 0.35 between PASE and
the Actigraph for the comparisons with the expected
highest correlation, with only the correlation between
the PASE item for moderate PA intensity and the
Table 2 Test-retest reliability of the PASE
PASE score Test, mean (SD) Retest, mean (SD) d, mean (95% CI) ICC2.1 (95% CI) SEM MDC
Total score (n = 33) 143 (71) 125 (56) 18 (-3,-32) 0.77 (0.56, 0.88) 31 87
Household/Work activities 114 (63) 84 (59) 15 (-1, 30) 0.69 (0.46, 0.84) 32 89
Leisure time PA 29 (24) 26 (19) 3 (-4, 10) 0.53 (0.24, 0.74) 15 40
Light PA intensity 13 (22) 10 (11) 3 (-4, 9) 0.46 (0.15, 0.69) 13 35
Moderate PA intensity 9 (10) 9 (13) 1 (-5, 6) 0.20 (-0.16, 0.51) 10 28
Vigorous PA intensity 4 (6) 5 (7) -1 (-2, 1) 0.68 (0.44, 0.83 4 10
PA physical activity, PASE Physical Activity Scale for the Elderly, d: difference between test and retest, ICC2.1 intraclass correlation coefficient, two-way random
effects ANOVA, SEM standard error of measurement, MDC minimal detectable change
Mean Total PASE Score, test and retest
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Figure 2 Bland-Altman plot for total PASE score. Intra-individual differences (n = 33) plotted against the difference between test and retest
scores for the total PASE score. The central horizontal line represents the mean difference, while the flanking lines represent the 95% limits of
agreement. The dotted line represents no difference between test and retest.
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cance. The correlation coefficients ranged from 0.29 to
0.75 between PASE and IPAQ for the comparisons with
the expected highest correlation. Of these, the correla-
tion between the PASE score for moderate PA intensity
and the IPAQ score for walking, and the PASE score for
vigorous PA intensity and the IPAQ score for vigorous
PA intensity reached statistical significance.
Discussion
This is the first study to address the test-retest reliability
and the construct validity of the PASE in patients with
hip OA, and the first study to evaluate the validity of
the Norwegian version of the PASE. It is also one of
relatively few studies evaluating the construct validity of
a self-administered instrument for assessing PA by com-
paring it to an accelerometer, a method for direct mea-
surement of PA, in patients with OA[13].
In our study we found that 67% of patients with hip
OA fulfilled the recommendations of achieving at least
30 minutes of accumulated MVPA per day, but only
30% fulfilled the recommendations of achieving at least
30 minutes of MVPA per day in blocks of minimum 10
minutes. However, a larger percentage of the hip OA
patients did fulfill the recommendations compared to
the general Norwegian population. Only 20% of the gen-
eral adult Norwegian population fulfill these recommen-
dations, and a decline in the amount of PA was present
after the age of 64 years. Mean counts per minute was
338, compared to 370 in our study[28]. The patients in
our study were found to have high levels of PA when
compared to other studies investigating levels of PA by
accelerometers in OA patients[4,5,32]. Hirata et al.[32]
found that women with hip OA were engaged in MVPA
for 17 minutes per day, and only 14% met the recom-
mendations of more than 30 minutes accumulated
MVPA per day[32]. For patients with knee OA mean
time spent on MVPA was 14-25 minutes per day[4,5]
and 30% met the recommendations[4]. However, studies
on PA levels in patients with knee OA may not be a
valid comparison for the patients in our study. These
previous studies[4,5,32] may have included patients with
more progressive and severe OA than we did in our
study, where patients with a Harris Hip Score below 60
points were excluded from participation. It is also
important to stress that the hip OA patients in our
study originally participated in a RCT where the impor-
tance of PA was emphasized through a patient educa-
tion program, and this may have altered their PA levels.
However, no changes in total PASE score was found for
the 16 months follow-up of the RCT[20]. In addition,
the possibility for selection bias is present, i.e. patients
with a more positive attitude to PA might have been
more likely to participate, and the education level was
high. Thirty-nine percent of the patients in our study
had more than 12 years of education, compared to 28%
in the general Norwegian population (http://www.ssb.
no/utniv). The levels of PA found in this study may
therefore not be representative for the hip OA popula-
tion in general.
Table 3 Construct validity of the total PASE score, and the scores for light, moderate and vigorous PA intensity
Mean
(SD)
Total
score
Score for Light PA
intensity
Score for Moderate PA
intensity
Score for Vigorous PA
intensity
Actigraph GT1M
Average counts per minute, counts/
min
370
(199))
0.30
Total minutes in interval counts 0-99,
min
4015
(736)
Total minutes in interval counts 100-
2019, min
1989
(669)
0.20 0.21 0.21
Total minutes in interval counts 2020-
5999, min
294 (194) 0.46** 0.38* 0.11
Total minutes in interval counts >
6000, min
25 (50) 0.20 0.08 0.29
IPAQ
Total IPAQ, MET-min/week 3476
(3609)
0.61**
Walking MET-min/week 2098
(3145)
0.31 0.58** 0.05
Moderate Intensity, MET-min/week 707 (678) 0.20 0.29 0.16
Vigorous Intensity, MET-min/week 526 (869) 0.02 0.06 0.75**
PA physical activity, PASE Physical Activity Scale for the Elderly, IPAQ International Physical Activity Questionnaire, The categories of PASE and Actigraph GT1M
and of PASE and IPAQ with the highest expected correlation coefficients are highlighted by bold text
*: significant at 0.05-level; **: significant at 0.01-level
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of elderly Norwegians using PASE to assess physical
activity[26]. The mean totalP A S Es c o r ew a s1 2 7 ,q u i t e
consistent with the findings in our study on hip OA
patients, where total PASE score was 143 and 125 at
test and retest, respectively.
Measurement properties of an instrument are related
to the population and context in which it is being used.
In this study we evaluated the test-retest reliability of
the PASE in patients with hip OA by calculating the
ICC2.1, and in addition estimating the standard error of
measurement (SEM) and the minimal detectable change
(MDC). There are no absolute consensus regarding lim-
its for what should be considered an acceptable ICC
value. When instruments for assessing PA is evaluated,
Terwee et al.[13,15] and Forsèn et al.[33] have sug-
gested, and used, 0.70 as a cut-off for acceptable test-
retest reliability. Based on this the test-retest reliability
for the total PASE score was considered to be accepta-
ble, with an ICC2.1 of 0.77. However, Terwee et al.[34]
also suggested that the lower limit of the 96% CI of the
I C Cs h o u l de x c e e d0 . 6 0 ,a n df o rt h et o t a lP A S Es c o r e
the lower 95% CI was slightly lower than this, 0.56. The
Norwegian version of PASE has previously been found
to have acceptable reliability when tested in the general,
elderly population, with an internal consistency of items
(Cronbach’s alpha) of 0.73, and test-retest reliability
coefficient (Pearson’s) of 0.93-0.99[26].
T h eS E Ma n dM D Co ft h et o t a lP A S Es c o r ew e r e3 1
and 87, respectively, indicating that 87 represents the
smallest within-person change in score that can be
interpreted as a real change, exceeding measurement
error. However, a change exceeding the measurement
error is not necessarily clinically relevant, which can be
evaluated by estimating the Minimal Clinically Impor-
tant Difference (MCID). It is advised that the MCID is
estimated by using an anchor-based approach [35-37].
However, distribution-based approaches for estimating
the MCID are also proposed, and the MCID has been
found to equal approximately 0.5 SD at baseline[38] or
a p p r o x i m a t e l yo n eS E M [ 3 9 ] .T ob ea b l et od i s t i n g u i s h
important changes from measurement error and to mea-
sure changes over time, the MCID should exceed the
MDC[15], but by the smallest possible limit. The LoA
indicates that if a subject completes a questionnaire
twice, the second score could be as much as these limits
smaller or larger than the first score, due to measure-
ment error. Thus, the MCID should also lie outside the
LoA[15]. Despite an acceptable test-retest ICC of the
total PASE score, we consider the reliability to be mod-
erate, due to large measurement error and wide LoA
when compared to the mean total PASE score.
In our study, a significant decline in total PASE score
of 18 points was present from test to retest, indicating a
systematic error. We may therefore question whether
t h es i t u a t i o no rt h es u b j e c t sa c t u a l l yw e r es t a b l e .W h e n
systematic error is present, this is often believed to
occur due to a learning effect. However, this is not likely
to be the case when the instrument of interest is a self-
administered questionnaire. A more plausible explana-
tion may be that wearing the Actigraph GT1M encour-
aged the patients to increase their activity levels, during
the week the PASE referred to. According to Reiser and
Schlenk[40] direct observations of PA by accelerometry
may modify the pattern and level of PA among the par-
ticipants, and may therefore bias the results.
Furthermore, this study evaluated the construct validity
of the PASE by comparing it to an accelerometer, the
Actigraph GT1M, and with another PA questionnaire,
the IPAQ. As proposed by Terwee et al.[30] we tested
predefined specific hypotheses including the expected
direction and magnitude of correlations. In this study we
found no significant correlation between the total PASE
s c o r ea n dt h eA c t i g r a p hG T 1M mean total counts per
minute. The correlation coefficient was 0.30, in line with
our a priori hypothesis. It was comparable to previous
studies investigating the correlation between PASE and
accelerometers in different populations, where correla-
tions between 0.16-0.52 have been reported[17-19,41,42].
The correlation did not reach the cut-off for what we
considered satisfactory correlation, above 0.50, as sug-
gested by Terwee et al.[15]. Whereas self-reporting PA
questionnaires is found to over-report levels of PA com-
pared to accerelometers[43,44], Leenders et al.[45] found
that accelerometers significantly underestimated PA
related energy expenditure when compared to the doubly
labelled water method. This may be due to some of its
limitations. Accelerometers can of course only provide
measurements for the particular time it is observed and
recorded, cannot measure water exercises, and also fails
to measure activities such as cycling and upper limb
exercise correctly. Overestimation of total PA levels
when using questionnaires and underestimation when
using accelerometers, may to some degree explain the
discrepancy between the two methods for measuring PA.
The correlation between total PASE score and IPAQ
MET-minutes per week was moderate, with a correla-
tion of 0.61, and barely within our a priori hypothesize
of correlation between 0.6 and 0.9. Both PASE and
IPAQ are self-administered with a seven day recall per-
iod, but household- and work activities is included in
the PASE and weighed quite highly, whereas the IPAQ
mainly captures leisure-time PA. This may, at least
partly, explain the discrepancy between the two ques-
tionnaires. Both questionnaires were originally devel-
oped for use in a general population (generic), with
PASE being specifically designed for an elderly
population.
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report different PA intensity levels separately. One
might therefore argue that acceptable test-retest reliabil-
ity for the overall score is what is important. However,
assessment of intensity seems valuable when investigat-
ing the effect of exercise and PA, especially for evaluat-
ing the dose-response relationship and to establish
recommendations for patients with OA regarding
amount and intensity. We therefore wanted to evaluate
t h e s es p e c i f i ci t e m s ,t oe v a l u a t ew h e t h e raP Aq u e s t i o n -
n a i r ei sa b l et op r o v i d er e l i a b l ea n dv a l i dd a t af o rP A
intensity. The ICC2.1 for the sub-scores for household/
work-related PA and for leisure-time PA was 0.69 and
0.53, respectively, and the ICC2.1 for the items for light,
moderate and vigorous PA intensity was 0.46, 0.20 and
0.68, respectively. None of the ICC’sf o rt h es u b - s c o r e s
or the single item scores exceeded 0.7, which we inter-
preted as a cut-off for acceptable reliability, and the 95%
CI were wide for all the sub-scores and items. The SEM
and the MDC were also large compared to the mean
values of the sub-scores and items, indicating moderate
to low reliability.
Our a priori hypothesis; that the respective intensity
categories of the PASE would correlate strongest with
the respective intensity categories of the Actigraph
GT1M, was confirmed for moderate PA intensity and
vigorous PA intensity, but not for light PA intensity.
However, all correlation coefficients were below 0.46.
This indicated that the intensity items of the PASE were
not able to distinguish between light, moderate and vig-
orous PA intensity, and we therefore consider the PASE
not to be valid or reliable for assessing PA intensity.
The item for moderate PA intensity of PASE correlated
stronger with the IPAQ category for walking than the
IPAQ category for moderate PA intensity. This may be
due to the fact that the IPAQ includes a specific item
for assessing walking activities, whereas walking activ-
ities are included in the items for light, moderate and
vigorous PA intensity in the Norwegian version of
PASE. Walking is a widespread leisure time activity in
Norway, and is likely to be scored in the item for mod-
erate PA intensity of the PASE, giving a higher correla-
tion with the IPAQ walking compared to the IPAQ
moderate PA intensity.
This study has some limitations. Both analysis of test-
retest reliability and construct validity by comparing
PASE to the Actigraph GT1M were based on data
obtained from 33 patients. After referring a statistician,
and based on that other studies have used similar sam-
ple sizes[19,33], we decided to include 40 patients in
this study. According to the statistician a sample size
between 30 and 40 is usually sufficient when evaluating
outcome measurements that uses a continuous scale.
According to Terwee et al.[15] sample size in reliability
and/or validity studies evaluating PA assessment tools
should exceed 50. A recently developed scoring system
for rating methodological quality of measurement prop-
erties suggests that a sample size of 100 should be con-
sidered excellent, 50 as good, 30 as fair and under 30 as
poor[46]. Correlation between PASE and IPAQ was only
b a s e do nd a t af r o m2 5p a t i e n t s .T h eN o r w e g i a nv e r s i o n
of IPAQ has been validated for the Norwegian popula-
tion, but has included an item “don’tk n o w ” as an
option for duration of activity which challenge the inter-
pretation and the score calculations.
The use of Actigraph GT1M and the IPAQ to evalu-
ate construct validity have some weaknesses. The doubly
labeled water method is often considered to be the gold
standard for measuring PA[15], but is seldom used to
evaluate validity of PA questionnaires, as it is expensive,
time-consuming and relies on access to both technical
expertise and equipment. Only two studies have vali-
dated the PASE by comparing it to doubly labelled
water, and found correlation coefficients of 0.28[47] and
0.68[48]. However, the doubly labelled water method is
affected by the basal metabolic rate, and it cannot cap-
ture frequency, duration and intensity of activity. Accel-
erometers may therefore represent a more appropriate
comparator because it can provide information on
amount, pattern and intensity of PA, and therefore seem
to measure the same construct as most PA question-
naires[15]. There is evidence for reasonable correlation
between waist-worn accelerometers and the doubly
labelled water method in adults, with correlations ran-
ging from 0.30-0.83[49]. IPAQ was also included as a
comparator because it is a widely used PA question-
naire, but like other questionnaires it is vulnerable to
recall and reporting bias. Previous studies comparing
IPAQ and accelerometers/activity monitors have
reported correlation coefficients between 0.29 to 0.35
[50-52]. However, Ainsworth[53] states that question-
naires may be suitable for assessing PA for most
patients. More sophisticated methods, like acceler-
ometers, provide more precise measurements, but are
less practical for use in clinical settings. Kayes and
McPherson[54] emphasize that PA questionnaires and
accelerometers both have weaknesses, but that both
methods are likely to assess important aspects of the PA
construct. Use of both tools may therefore be appropri-
ate to capture all aspects of PA.
Conclusions
The test-retest reliability of the total PASE score in
patients with hip OA was found to be moderate, based
on an acceptable ICC2.1, but the large SEM, SDC and
LoA indicate large measurement errors. The construct
validity of the total PASE score was found to be poor
when compared to the Actigraph GT1M accelerometer.
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Page 8 of 10These findings suggest that PASE is not sufficient for
assessing PA levels and intensity in patients with hip
OA. Accelerometers provide a more precise tool of
assessing amount and intensity of PA, and should pre-
ferably be included if feasible in studies where these
dimensions are considered important.
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